This page is part of the Pharmaceutical Clinical Trial Protocols (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
Page standards status: Trial-use | Maturity Level: 2 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="m11-phase-vs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet m11-phase-vs</b></p><a name="m11-phase-vs"> </a><a name="hcm11-phase-vs"> </a><ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/6.5.0/CodeSystem-v3-nciThesaurus.html"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C54721</td><td>Early Phase 1</td></tr><tr><td>C15600</td><td>Phase 1</td></tr><tr><td>C15693</td><td>Phase 1/Phase 2</td></tr><tr><td>C198366</td><td>Phase 1/Phase 2/Phase 3</td></tr><tr><td>C198367</td><td>Phase 1/Phase 3</td></tr><tr><td>C217024</td><td>Phase 2/Phase 3/Phase 4</td></tr><tr><td>C15601</td><td>Phase 2</td></tr><tr><td>C15694</td><td>Phase 2/Phase 3</td></tr><tr><td>C217025</td><td>Phase 3/Phase 4</td></tr><tr><td>C15602</td><td>Phase 3</td></tr><tr><td>C15603</td><td>Phase 4</td></tr></table></li></ul></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="2"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="brr"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
<valueCode value="trial-use">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/pharmaceutical-research-protocol/ImplementationGuide/hl7.fhir.uv.pharmaceutical-research-protocol"/>
</extension>
</valueCode>
</extension>
<url
value="http://hl7.org/fhir/uv/pharmaceutical-research-protocol/ValueSet/m11-phase-vs"/>
<version value="1.0.0-ballot"/>
<name value="M11PhaseVS"/>
<title value="M11 Phase Value Set"/>
<status value="draft"/>
<experimental value="false"/>
<date value="2025-08-01T12:18:30+00:00"/>
<publisher value="HL7 International / Biomedical Research and Regulation"/>
<contact>
<name value="HL7 International / Biomedical Research and Regulation"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/rcrim"/>
</telecom>
<telecom>
<system value="email"/>
<value value="UDP@HL7Vulcan.org"/>
</telecom>
</contact>
<description
value="Codes drawn from NCI Thesaurus value set $NCIT#C217045 ICH M11 Trial Phase Value Set Terminology
These codes represent phases of a study as defined by ICH."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<compose>
<include>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<concept>
<code value="C54721"/>
<display value="Early Phase 1"/>
</concept>
<concept>
<code value="C15600"/>
<display value="Phase 1"/>
</concept>
<concept>
<code value="C15693"/>
<display value="Phase 1/Phase 2"/>
</concept>
<concept>
<code value="C198366"/>
<display value="Phase 1/Phase 2/Phase 3"/>
</concept>
<concept>
<code value="C198367"/>
<display value="Phase 1/Phase 3"/>
</concept>
<concept>
<code value="C217024"/>
<display value="Phase 2/Phase 3/Phase 4"/>
</concept>
<concept>
<code value="C15601"/>
<display value="Phase 2"/>
</concept>
<concept>
<code value="C15694"/>
<display value="Phase 2/Phase 3"/>
</concept>
<concept>
<code value="C217025"/>
<display value="Phase 3/Phase 4"/>
</concept>
<concept>
<code value="C15602"/>
<display value="Phase 3"/>
</concept>
<concept>
<code value="C15603"/>
<display value="Phase 4"/>
</concept>
</include>
</compose>
</ValueSet>